Universal Biosensors, Inc. (UBI.AX)
AUD 0.13
(0.0%)
AUD 0.13
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -6.74 Million AUD | 74.9% |
| 2022 | -26.85 Million AUD | -160.68% |
| 2021 | -10.3 Million AUD | -34.37% |
| 2020 | -7.66 Million AUD | -58.2% |
| 2019 | -4.84 Million AUD | -112.9% |
| 2018 | 37.56 Million AUD | 5012.19% |
| 2017 | -764.71 Thousand AUD | -161.16% |
| 2016 | 1.25 Million AUD | 119.01% |
| 2015 | -6.57 Million AUD | 29.41% |
| 2014 | -9.31 Million AUD | 19.92% |
| 2013 | -11.63 Million AUD | -27.41% |
| 2012 | -9.13 Million AUD | 37.85% |
| 2011 | -14.69 Million AUD | -122.25% |
| 2010 | -6.61 Million AUD | -562.12% |
| 2009 | 1.43 Million AUD | 111.92% |
| 2008 | -11.99 Million AUD | -42.68% |
| 2007 | -8.4 Million AUD | -185.48% |
| 2006 | -2.94 Million AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -3.43 Million AUD | -96.38% |
| 2024 Q2 | -3.79 Million AUD | -10.33% |
| 2024 Q3 | -3.4 Million AUD | 10.14% |
| 2023 FY | -6.74 Million AUD | 74.9% |
| 2023 Q2 | 1.39 Million AUD | 136.87% |
| 2023 Q1 | -3.79 Million AUD | 70.01% |
| 2023 Q3 | -2.6 Million AUD | -285.91% |
| 2023 Q4 | -1.75 Million AUD | 32.66% |
| 2022 Q3 | -4.92 Million AUD | -7.31% |
| 2022 Q4 | -12.65 Million AUD | -156.94% |
| 2022 FY | -26.85 Million AUD | -160.68% |
| 2022 Q1 | -4.56 Million AUD | -3.25% |
| 2022 Q2 | -4.58 Million AUD | -0.49% |
| 2021 Q1 | -1.43 Million AUD | -41.12% |
| 2021 Q3 | -2.87 Million AUD | -61.53% |
| 2021 Q4 | -4.42 Million AUD | -53.81% |
| 2021 Q2 | -1.77 Million AUD | -24.43% |
| 2021 FY | -10.3 Million AUD | -34.37% |
| 2020 Q2 | -3.06 Million AUD | -109.15% |
| 2020 Q3 | -2.1 Million AUD | 31.33% |
| 2020 FY | -7.66 Million AUD | -58.2% |
| 2020 Q1 | -1.46 Million AUD | -171.17% |
| 2020 Q4 | -1.01 Million AUD | 51.77% |
| 2019 Q3 | -806.56 Thousand AUD | 15.92% |
| 2019 FY | -4.84 Million AUD | -112.9% |
| 2019 Q4 | -539.53 Thousand AUD | 33.11% |
| 2019 Q2 | -959.28 Thousand AUD | 62.25% |
| 2019 Q1 | -2.54 Million AUD | 33.62% |
| 2018 FY | 37.56 Million AUD | 5012.19% |
| 2018 Q4 | -3.82 Million AUD | -109.14% |
| 2018 Q3 | 41.86 Million AUD | 7610.08% |
| 2018 Q2 | -557.45 Thousand AUD | -765.06% |
| 2018 Q1 | 83.82 Thousand AUD | 104.02% |
| 2017 Q4 | -2.08 Million AUD | -76.45% |
| 2017 FY | -764.71 Thousand AUD | -161.16% |
| 2017 Q1 | 2.36 Million AUD | -48.66% |
| 2017 Q2 | 134.74 Thousand AUD | -94.3% |
| 2017 Q3 | -1.18 Million AUD | -976.28% |
| 2016 Q1 | -1.65 Million AUD | 27.6% |
| 2016 FY | 1.25 Million AUD | 119.01% |
| 2016 Q3 | -2.16 Million AUD | -568.21% |
| 2016 Q2 | 461.82 Thousand AUD | 127.91% |
| 2016 Q4 | 4.6 Million AUD | 313.0% |
| 2015 Q2 | -1.25 Million AUD | 56.07% |
| 2015 Q4 | -2.28 Million AUD | -1303.66% |
| 2015 Q3 | -162.85 Thousand AUD | 87.07% |
| 2015 Q1 | -2.86 Million AUD | -510.91% |
| 2015 FY | -6.57 Million AUD | 29.41% |
| 2014 Q1 | -3.59 Million AUD | -10.12% |
| 2014 FY | -9.31 Million AUD | 19.92% |
| 2014 Q4 | -469.42 Thousand AUD | 75.22% |
| 2014 Q3 | -1.89 Million AUD | 43.54% |
| 2014 Q2 | -3.35 Million AUD | 6.75% |
| 2013 Q2 | -3.04 Million AUD | 34.5% |
| 2013 Q1 | -4.64 Million AUD | -5.66% |
| 2013 FY | -11.63 Million AUD | -27.41% |
| 2013 Q4 | -3.26 Million AUD | -378.11% |
| 2013 Q3 | -683.32 Thousand AUD | 77.53% |
| 2012 Q3 | -1.32 Million AUD | -31.46% |
| 2012 FY | -9.13 Million AUD | 37.85% |
| 2012 Q2 | -1 Million AUD | 58.01% |
| 2012 Q1 | -2.4 Million AUD | 0.0% |
| 2012 Q4 | -4.39 Million AUD | -231.36% |
| 2011 Q1 | -3.04 Million AUD | 0.0% |
| 2011 FY | -14.69 Million AUD | -122.25% |
| 2011 Q3 | -3.35 Million AUD | 31.67% |
| 2011 Q2 | -4.9 Million AUD | -61.12% |
| 2010 Q1 | -1.09 Million AUD | 0.0% |
| 2010 Q3 | -1.5 Million AUD | 40.56% |
| 2010 Q2 | -2.52 Million AUD | -130.65% |
| 2010 FY | -6.61 Million AUD | -562.12% |
| 2009 Q3 | -4.01 Million AUD | 13.6% |
| 2009 FY | 1.43 Million AUD | 111.92% |
| 2009 Q2 | -4.64 Million AUD | -97.25% |
| 2009 Q1 | -2.35 Million AUD | 0.0% |
| 2008 FY | -11.99 Million AUD | -42.68% |
| 2007 FY | -8.4 Million AUD | -185.48% |
| 2006 FY | -2.94 Million AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| 4DMedical Limited | -35.97 Million AUD | 81.262% |
| Adherium Limited | -10.22 Million AUD | 34.063% |
| Aroa Biosurgery Limited | -9.74 Million AUD | 30.843% |
| Atomo Diagnostics Limited | -6.84 Million AUD | 1.551% |
| Anteris Technologies Ltd | -67.33 Million AUD | 89.988% |
| Control Bionics Limited | -5.91 Million AUD | -13.998% |
| CardieX Limited | -6.76 Million AUD | 0.352% |
| Compumedics Limited | -338 Thousand AUD | -1894.546% |
| Cochlear Limited | 356.8 Million AUD | 101.889% |
| CleanSpace Holdings Limited | -3.12 Million AUD | -115.582% |
| Cyclopharm Limited | -4.7 Million AUD | -43.413% |
| EMVision Medical Devices Ltd | -2.72 Million AUD | -146.979% |
| Nova Eye Medical Limited | -8.79 Million AUD | 23.304% |
| HeraMED Limited | -6.78 Million AUD | 0.621% |
| Imricor Medical Systems, Inc. | -22.62 Million AUD | 70.204% |
| ImpediMed Limited | -19.79 Million AUD | 65.934% |
| InhaleRx Limited | -1.44 Million AUD | -367.103% |
| LBT Innovations Limited | -3.74 Million AUD | -80.256% |
| Micro-X Limited | -9.76 Million AUD | 30.962% |
| Neurotech International Limited | -5.06 Million AUD | -32.989% |
| OncoSil Medical Limited | -11.91 Million AUD | 43.413% |
| PolyNovo Limited | 5.26 Million AUD | 228.142% |
| Respiri Limited | -7.12 Million AUD | 5.438% |
| SomnoMed Limited | -12.24 Million AUD | 44.93% |
| Uscom Limited | -2.07 Million AUD | -224.934% |
| Visioneering Technologies, Inc. | -5.06 Million AUD | -33.145% |